GlassScriptPhysician profile
Parth K Shah
NPI 1184037590
$29,660.70
in general payments reported to CMS, 2019-2025
46 companies · $6,919 in 2025
The $6,919 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,426 · 2020: $1,301 · 2021: $482 · 2022: $610 · 2023: $11K · 2024: $7,814 · 2025: $6,919.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $15K · Education: $4,500 · Travel and Lodging: $3,171 · Food and Beverage: $3,138.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,032.00 |
| Education | $4,500.00 |
| Travel and Lodging | $3,171.10 |
| Food and Beverage | $3,138.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corbin Clinical Resources | $15,032.00 | 2023-2024 | |
| Intuitive Surgical, INC. | $7,185.28 | 2023-2025 | Da Vinci Surgical System |
| Boston Scientific Corporation | $1,622.58 | 2019-2024 | Lithovue, Rezum Generator |
| Neotract INC. | $1,086.57 | 2020 | |
| Procept Biorobotics Corporation | $945.81 | 2024-2025 | Aquabeam System |
| Astellas Pharma US INC | $470.52 | 2019-2024 | Xtandi |
| Olympus America INC. | $379.47 | 2020-2025 | Itind System |
| Urogen Pharma, INC. | $289.69 | 2024-2025 | |
| Abbvie INC. | $242.31 | 2020-2025 | |
| Calyxo, INC. | $213.53 | 2024-2025 | Cvac Aspiration System |
| Sumitomo Pharma America, INC. | $200.42 | 2024-2025 | Gemtesa, Orgovyx |
| Teleflex LLC | $184.89 | 2021-2024 | Urolift |
| Verity Pharmaceuticals INC. | $179.59 | 2024-2025 | Trelstar |
| Koelis INC. | $163.60 | 2023 | |
| Axonics, INC. | $149.15 | 2023 | Axonics |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Parth Shah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.